Public Awareness and Identification of Counterfeit Drugs in Tanzania: A View on Antimalarial Drugs
Advances in Public Health, 2016 Background. The illicit trade in counterfeit antimalarial drugs is a major setback to the fight against malaria. Information on public awareness and ability to identify counterfeit drugs is scanty. Aim.
Linus Mhando +4 more
doaj +1 more source
Brazilian Journal of Pharmaceutical Sciences, 2022 The illicit market of counterfeit medicines containing sildenafil and tadalafil has been causing serious public health problems. Thus, further studies on this illicit association are needed.
Mayara Aramburú Pinto +6 more
doaj +1 more source
Simple field assays to check quality of current artemisinin-based antimalarial combination formulations. [PDF]
, 2009 INTRODUCTION: Malaria continues to be one of the major public health problems in Africa, Asia and Latin America. Artemisinin derivatives (ARTs; artesunate, artemether, and dihydroartemisinin) derived from the herb, Artemisia annua, are the most effective
Ioset, Jean-Robert +5 more
core +1 more source
Combatting counterfeit drugs: Case studies of Cambodia, Vietnam and Thailand [PDF]
, 2017 Medicines can save lives only if they are safe, efficacious, of good quality and affordable. The use of unsafe, substandard, ineffective and counterfeit drugs can be harmful to the health of the users and the public.
Jakkrit Kuanpoth (20122242)
core +3 more sources
IR Spectroscopic Analytical Tools in the Fight Against Counterfeit Medicines [PDF]
, 2023 Counterfeit medicines pose a huge and growing threat to public health globally and have consequences for healthcare systems and economies worldwide. These poor-quality medicines impact on public health not only in low-resource countries but also in the ...
Tanna, Sangeeta, Armitage, Rachel
core
Inequities in valuation of benefits, choice of drugs, and mode of payment for malaria treatment services provided by community health workers in Nigeria. [PDF]
, 2007 This study determined inequities of using community health workers (CHWs) for timely and appropriate treatment of malaria in terms of: 1) valuation of benefits; 2) actual purchase of drugs; and 3) payment modality in southeast Nigeria.
Ojukwu, Juliana +3 more
core +1 more source
Assessment of Prevalence of Counterfeit Drugs in Developing Countries [PDF]
, 2021 This data is raw data generated from respondents across developing countries on counterfeit drugs and the major contributors to the prevalence of this act in their ...
Onuh, G (via Mendeley Data)
core +1 more source
Quality of antimalarial drugs and antibiotics in Papua New Guinea : a survey of the health facility supply chain [PDF]
, 2014 Poor-quality life-saving medicines are a major public health threat, particularly in settings with a weak regulatory environment. Insufficient amounts of active pharmaceutical ingredients (API) endanger patient safety and may contribute to the ...
Betuela Inoni +33 more
core +1 more source
Good quality locally procured drugs can be as effective as internationally quality assured drugs in treating multi-drug resistant tuberculosis. [PDF]
, 2015 BACKGROUND: Owing toGiven the high costs of drugs to treat multi-drug resistant tuberculosis (MDR-TB), the Green Light Committee (GLC) initiative enables TB programs to procure quality-assured drugs at reduced prices.
David Moore +23 more
core +1 more source
Counterfeit drugs in India: significance and impact on pharmacovigilance [PDF]
, 2017 Counterfeit drugs have emerged as a major global problem. This issue has been brought to the centre of the Indian media due to the death of 15 women attending a sterilization camp in Chhattisgarh.
Sattigeri, Bhagya M. +3 more
core +2 more sources